Key Points for Choosing a Direct-Operating IVF Hospital in Kyrgyzstan & Full Process Guide

Opening: Real Consultation Scenario

Consultation Scenario · A 43-year-old woman, AMH 0.6, after two failed IVF attempts in China, came to me with three large binders of test reports and different plans from three agencies. She asked three questions: What is the real difference between those hospitals in Kyrgyzstan that claim to be direct-operating and the ones introduced by domestic agencies? How can I tell if it is truly direct-operating? If I go directly, what is the process?

What is a Direct-Operating IVF Hospital in Kyrgyzstan

Direct-operating hospital refers to a fertility center directly operated and managed by the hospital's investor or parent medical group, owning its own physical facility, in-house laboratory, and full-time embryologist team in the country, with no third-party agency or intermediary referral in mainland China. Patients liaise directly with the hospital; all costs, plans, and test results are issued and explained directly by the hospital, with no information filtering or markup in between.

To determine if it is a direct-operating hospital, at least the following conditions must be met:

• The hospital's registration information and practice license number can be verified on the official website of the Ministry of Health of Kyrgyzstan;
• It has an independent embryology laboratory with corresponding international quality control certifications (such as ISO 15189 or equivalent standards);
• Patients can book an initial consultation directly through the hospital's official channels (official website, official email, official phone number) without needing to go through a third party;
• The detailed cost breakdown is issued directly by the hospital, and the payment account is the hospital's corporate account, not a personal or third-party company account.

Reproductive Doctor's Perspective: Core Differences Between Direct-Operating and Agency

Within the assisted reproduction industry, the biggest difference between a direct-operating hospital and an agency is not the success rate number, but the independence of medical decisions and the integrity of information transfer. Doctors at direct-operating hospitals face patients directly, formulating plans based on original test reports and real-time physical responses, without third-party interference or distortion of medical judgment. In the agency referral model, patients go through at least two to three rounds of information transfer from the initial consultation to starting the cycle, and each step may lose key details—such as the interpretation of AMH values, description of endometrial morphology, or specific medication responses in previous cycles.

A common observation from ten years in the field: some patients referred overseas through agencies find upon arrival at the hospital that the plan does not fully match their expectations or physical condition, because the agency oversimplified or "glamorized" the information during initial communication. The direct-operating model minimizes this kind of information loss to the greatest extent.

Differences Between Kyrgyzstan and Other Overseas IVF Destinations

Families choosing Kyrgyzstan as their IVF destination often compare it horizontally with Kazakhstan, Georgia, Thailand, etc. The differences are listed below from several key dimensions:

Direct-operating hospitals in Kyrgyzstan offer certain advantages in cost transparency and direct communication, but patients need to take on more preliminary research themselves, including verifying hospital credentials, confirming laboratory standards, and arranging translation.

Treatment Process at a Direct-Operating Hospital: From Initial Consultation to Transfer

Below is a complete standard process for an IVF cycle through a direct-operating hospital, typically spanning 28–36 days (excluding pre-cycle preparation and waiting time for PGT results).

Phase 1: Pre-cycle Preparation (Done in China, 1–3 months in advance)

• Basic fertility assessment: Female: AMH, FSH, LH, antral follicle count (AFC); Male: semen analysis (abstinence for 3–5 days).
• Infectious disease screening: Hepatitis B, Hepatitis C, HIV, Syphilis, etc. (required for both partners, valid for 6 months).
• Chromosomal karyotype analysis: Required for both partners, valid for life, but report should be obtained before starting the cycle.
• Uterine cavity evaluation: Ultrasound or hysteroscopy 3–7 days after menstruation ends to rule out polyps, adhesions, endometritis, etc.
• Document preparation: Passport (valid for at least 6 months), marriage certificate (notarized in Chinese and Russian), visa (e-visa).

Phase 2: Travel to Kyrgyzstan & Cycle Start (Approx. 14–16 days)

• Day 1–3: Arrive in Bishkek, register at the hospital, review test reports, sign informed consent, start ovarian stimulation.
• Day 6–10: Monitor follicle development every 1–2 days, adjust medication dosage.
• Day 11–13: Trigger injection when follicles are mature, egg retrieval 36 hours later.
• Day of egg retrieval: Sperm collection (or use frozen sperm), fertilization performed in the lab.

Phase 3: Embryo Culture & Transfer (Approx. 12–18 days)

• Day 1–5: Embryo culture in vitro, observe development to blastocyst stage on day 5–6.
• If PGT is required: Biopsy sampling and sending for testing; waiting time approx. 7–10 days.
• Transfer: Frozen or fresh embryo transfer scheduled based on endometrial preparation.
• 10–12 days after transfer: Blood test for HCG to confirm pregnancy.

Cost Breakdown: Transparent Structure Under the Direct-Operating Model

One of the biggest features of a direct-operating hospital is a relatively clear cost structure, but it is still necessary to confirm item by item whether all the following steps are included:

Total cost estimate: A complete cycle (without PGT) is approximately 45,000 – 68,000 RMB; adding PGT increases the cost by 15,000 – 25,000 RMB. Direct hospitals provide a written cost breakdown and specify which items are billed based on actual usage and which are package prices.

Five Most Easily Overlooked Details

• Actual operational standards of the laboratory: Does the direct hospital have full-time embryologists on site? Does the lab participate in external quality assessments? This information is more valuable than "success rate numbers."
• Degree of individualization of the stimulation protocol: Is the protocol adjusted based on AMH, AFC, and medical history, or is a fixed template used? Doctors at direct hospitals usually have more authority to make flexible adjustments.
• Specific medication for endometrial preparation before transfer: Natural cycle, artificial cycle, or stimulated cycle? Different preparation methods significantly affect endometrial receptivity and should be clearly documented.
• Embryo freeze-thaw survival rate: A direct hospital should be able to provide its embryo freeze-thaw survival rate data for the past 12 months. If they cannot, caution is needed.
• Remote follow-up arrangements: Does the hospital provide remote medication guidance and early pregnancy monitoring after transfer? Direct hospitals generally have a clear follow-up process.

Three Most Common Pitfalls

① Misled by "Direct-Operating" claims: Some institutions claim to be direct-operating but only rent an office near the hospital, still functioning as an agency or consulting company. The verification method is to directly ask for the hospital's official registered name and check it yourself on the website of the Ministry of Health of Kyrgyzstan.

② Hidden fees: Quotations may not include anesthesia fees, embryo freezing fees, sperm optimization fees, etc., which are charged separately upon arrival. A direct hospital should provide a list including all common items and include a "no additional charges" clause in the contract.

③ Expired or unrecognized test reports: Some test reports from domestic hospitals (especially chromosomal analysis and infectious disease screening) may not be directly recognized abroad and require retesting. Be sure to confirm with the direct hospital the list of accepted reports and their validity before departure.

Practitioner's Observation: Real Advantages and Limitations of the Direct-Operating Model

Having worked in the overseas assisted reproduction industry for ten years, I have observed the following real characteristics of the direct-operating model:

• Advantages: High communication efficiency; doctors have direct access to the patient's full medical history; costs are clear with a low probability of mid-course price changes; strong medical autonomy with flexible protocol adjustments.
• Limitations: Patients need to do a significant amount of preliminary research themselves, including verifying hospital credentials, arranging translation, and planning travel; direct hospitals are often smaller in scale and may have limited multidisciplinary consultation capabilities for complex comorbidities.
• Suitable for: Families with basic medical knowledge or who have done thorough research; patients who prefer to control the process and dislike passive arrangements; families with a moderate budget who want every expense to be transparent.

Direct-operating is not synonymous with "zero risk," but it reduces the decision-making risk caused by information asymmetry. The final choice of hospital still depends on the patient's own physical condition, budget range, and risk tolerance.

Overseas Assisted Reproduction Coordinator with 10 years of experience · Knowledge base content for learning reference only